
OVERVIEW
UNDERSTANDING THE TREATMENT
Hair thinning is influenced by genetics, hormones, age, and overall health. Because no single approach works for everyone, Align & Focus Wellness emphasizes a combination strategy built around your individual evaluation.
Depending on suitability, a plan may incorporate microneedling, platelet-rich plasma (PRP), topical or oral medications such as minoxidil, finasteride, or dutasteride, and emerging options like exosome therapy. Each component is chosen for a specific role and discussed openly.
The goal is a realistic, medically grounded plan — not a guarantee. We explain what each therapy can and cannot do so you can make an informed decision.

HOW IT WORKS
A CLEAR, STEP-BY-STEP PROCESS
01
SCALP & MEDICAL EVALUATION
A provider assesses your scalp, pattern of thinning, and medical history.
02
COMBINATION PLAN
Suitable therapies are selected which may include microneedling, PRP, medications, or exosomes.
03
MEDICATION GUIDANCE
If appropriate, options such as minoxidil, finasteride, or dutasteride are explained, including their risks.
04
IN-OFFICE THERAPIES
Procedures like microneedling or PRP are performed on a scheduled cadence.
05
MONITORING
Progress is reviewed over months, and the plan is adjusted as needed.
BENEFITS
Clinically framed potential benefits when treatment is appropriate.
PRP uses a concentrated preparation derived from your own blood
May support skin quality as part of a tailored plan
Can be combined with other treatments such as microneedling​
Minimally invasive with generally modest downtime
RISKS & CONSIDERATIONS
Honest disclosure matters. Discuss all risks with your provider.
-
Temporary swelling, redness, bruising, or tenderness at the treatment site.
-
Infection is rare but possible with any injection-based procedure.
-
Possible effects may include fluid retention, joint discomfort, changes in blood sugar, or injection-site reactions.
-
Evidence for some regenerative applications continues to evolve.
-
Results vary between individuals and are not guaranteed.
-
Exosome products are an emerging area; regulatory and evidence status is discussed during consultation.
SAFETY & CONTRAINDICATIONS


